Panacea Biotec (NSE:PANACEABIO) COGS-to-Revenue : 0.45 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Panacea Biotec COGS-to-Revenue?

Panacea Biotec's Cost of Goods Sold for the three months ended in Dec. 2023 was ₹673 Mil. Its Revenue for the three months ended in Dec. 2023 was ₹1,505 Mil.

Panacea Biotec's COGS to Revenue for the three months ended in Dec. 2023 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Panacea Biotec's Gross Margin % for the three months ended in Dec. 2023 was 55.27%.

Panacea Biotec COGS-to-Revenue Historical Data

The historical data trend for Panacea Biotec's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec COGS-to-Revenue Chart

Panacea Biotec Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

Get a 7-Day Free Trial

0.45

0.32

0.37

0.46

0.61

Panacea Biotec Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.41	0.66	0.42	0.41	0.45

Panacea Biotec COGS-to-Revenue Calculation

Panacea Biotec's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2787.58	/	4569.19
	=	0.61

Panacea Biotec's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	673.2	/	1505
	=	0.45

Panacea Biotec (NSE:PANACEABIO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Panacea Biotec's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	673.2 / 1505
	=	55.27 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Panacea Biotec COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (NSE:PANACEABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (NSE:PANACEABIO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

531349:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (NSE:PANACEABIO) Headlines

No Headlines